ClinicalTrials.Veeva
Menu

Find clinical trials for Kidney Disease in Portland, OR

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Kidney Diseases
Chronic Renal Insufficiency
Chronic Kidney Failure
IGA Glomerulonephritis
Renal Cell Carcinoma
Renal Insufficiency
Carcinoma

Kidney Disease trials near Portland, OR, USA:

Sotagliflozin to Slow Kidney Function Decline in Persons with Type 1 Diabetes and Diabetic Kidney Disease (SUGARNSALT)

Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors ...

Enrolling
Kidney Failure, Chronic
Diabetic Nephropathies
Drug: Placebo
Drug: Sotagliflozin

Phase 3

Alessandro Doria

Portland, Oregon, United States and 17 other locations

Primary Objective:Evaluate the effect of Hectorol® capsules in reducing elevated levels of intact parathyroid hormone (iPTH).Secondary Objectives:* E...

Active, not recruiting
Secondary Hyperparathyroidism-Chronic Kidney Disease
Drug: Doxercalciferol (GZ427397)
Drug: Calcitriol

Phase 3

Sanofi
Sanofi

Portland, Oregon, United States and 29 other locations

Researchers are looking for a better way to treat people with chronic kidney disease (CKD), a progressive decrease in the kidneys...

Enrolling
Chronic Kidney Disease
Type 1 Diabetes Mellitus
Other: Placebo
Drug: Finerenone

Phase 3

Bayer
Bayer

Portland, Oregon, United States and 83 other locations

Locations recently updated

Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...

Enrolling
Chronic Kidney Disease
Proteinuria
Drug: Finerenone (Kerendia, BAY94-8862)

Phase 3

Bayer
Bayer

Portland, Oregon, United States and 145 other locations

Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...

Enrolling
Chronic Kidney Disease
Proteinuria
Drug: Finerenone (Kerendia, BAY94-8862)
Drug: Placebo

Phase 3

Bayer
Bayer

Portland, Oregon, United States and 129 other locations

Safety and Efficacy of BION-1301 in Adults with IgA Nephropathy

Enrolling
Immunoglobulin A Nephropathy
IgA Nephropathy
Drug: Placebo
Drug: BION-1301

Phase 3

Chinook Therapeutics

Portland, Oregon, United States and 156 other locations

The main purpose of this study is to compare the Human Acellular Vessel (HAV) with arteriovenous fistula (AVF) when used for hemodialysis access

Active, not recruiting
End Stage Renal Disease
Vascular Access
Other: Hemodialysis
Procedure: Arteriovenous fistula (AVF)

Phase 3

Humacyte
Humacyte

Portland, Oregon, United States and 30 other locations

Locations recently updated

The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabete...

Active, not recruiting
Chronic Kidney Disease
Cardiovascular Diseases
Drug: Orforglipron
Drug: Insulin Glargine

Phase 3

Lilly
Lilly

Portland, Oregon, United States of America and 395 other locations

of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) ...

Enrolling
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
Allogeneic Hematopoietic Cell Transplant
Biological: tabelecleucel

Phase 3

Atara Biotherapeutics

Portland, Oregon, United States and 70 other locations

This is a multicenter, international, three-part, Phase 1 study designed to evaluate the safety, tolerability, and PK of rising single doses of AT-02...

Enrolling
Amyloidosis; Systemic
Other: AT-02 (Placebo)
Drug: AT-02

Phase 1

Attralus

Portland, Oregon, United States and 10 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems